Adverum Biotechnologies, Inc. (65) | Separation Agreements (5)
Recent Contracts
-
Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Rupert D'Souza, dated as of June 7, 2022
(Filed With SEC on August 11, 2022)
-
Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Angela Thedinga, dated October 1, 2021
(Filed With SEC on November 4, 2021)
-
Separation Agreement between Adverum Biotechnologies, Inc. and Thomas Leung, dated February 2, 2021
(Filed With SEC on May 6, 2021)
-
Separation Agreement between Adverum Biotechnologies, Inc. and Aaron Osborne, dated April 7, 2021
(Filed With SEC on May 6, 2021)
-
Separation Letter, dated May 1, 2019, between Adverum Biotechnologies, Inc. and Paul Cleveland
(Filed With SEC on August 8, 2019)